What is the recommended dose of Colistin (polymyxin E) for patients with normal or impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing of Colistin for Patients with Normal and Impaired Renal Function

For all patients with normal or impaired renal function, a loading dose of 9 million international units (MU) of colistin should be administered regardless of renal function to rapidly achieve therapeutic levels. 1, 2

Dosing for Patients with Normal Renal Function

  • A maintenance dose of 4.5 MU every 12 hours (equivalent to 9 MU/day) is recommended for patients with normal renal function 2
  • Alternative weight-based dosing is 2.5-5 mg/kg/day divided into 2-4 doses 2, 3
  • For critically ill patients with severe sepsis/septic shock and normal renal function, 4.5 million IU every 12 hours is recommended 1
  • In obese individuals, dosage should be based on ideal body weight 3

Dosing for Patients with Impaired Renal Function

  • Maintenance dose should be individually adjusted according to creatinine clearance 1
  • For mild renal impairment (CrCl 50-79 mL/min): 2.5 to 3.8 mg/kg/day divided into 2 doses 3
  • For moderate renal impairment (CrCl 30-49 mL/min): 2.5 mg/kg/day, once daily or divided into 2 doses 3
  • For severe renal impairment (CrCl 10-29 mL/min): 1.5 mg/kg every 36 hours 3

Special Populations

Patients on Renal Replacement Therapy

  • For patients on Continuous Renal Replacement Therapy (CRRT): A dose of at least 9 million IU/day is recommended 1, 2
  • For patients on Intermittent Hemodialysis: 2 million IU every 12 hours with a normal loading dose 1
  • Schedule dialysis toward the end of a colistin dosage interval for patients on Intermittent Hemodialysis 1
  • Polymyxin B may be a suitable alternative as it doesn't require dose adjustment during CRRT 1, 4

Administration Methods

  • A 4-hour infusion is suggested to optimize pharmacokinetic/pharmacodynamic properties 1, 2
  • Direct intermittent administration: Slowly inject one-half of the total daily dose over a period of 3 to 5 minutes every 12 hours 3
  • Continuous infusion: Slowly inject one-half of the total daily dose over 3 to 5 minutes, then add the remaining half to compatible IV solutions for infusion over the next 22-23 hours 3

Important Considerations

  • Colistin is administered as colistimethate sodium (CMS), an inactive prodrug 1, 2
  • One million IU of colistin is equivalent to 80 mg of CMS 1, 2, 4
  • Renal function should be closely monitored during colistin therapy 2, 5
  • Higher colistin doses are associated with better microbiological clearance but also with increased risk of nephrotoxicity 5
  • Studies have shown that higher doses (9 MU/day) are associated with better microbiological clearance (66.2%) in critically ill patients 6

Common Pitfalls and Caveats

  • Underdosing is a common problem, particularly in critically ill patients with serious infections 7, 5
  • The recommended dose may be inadequate to maintain optimal pharmacokinetic/pharmacodynamic parameters for some pathogens, particularly Pseudomonas species 7
  • Acute kidney injury is a significant concern, with studies reporting nephrotoxicity rates of 8-39.3% 6, 8
  • Dose recommendations should be based primarily on creatinine clearance rather than body weight 7
  • Polymyxin B may be associated with lower incidence of renal failure compared to colistin 1, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.